Off-Label Compliance 2011

Attendees will learn how to minimize risk in off-label discussions and ensure that doctors are properly educated on products. In addition, attendees will learn how to strike a balance between increased sales revenue, increased development time and expanding indications; which is a lengthy and costly process.They will hear about successful compliance plans, effective business practices, and winning litigation tactics from leading in-house counsel, compliance and regulatory officers, and expert attorneys who represent the pharmaceutical and device industries. Finally, attendees will walk away with a better understanding of how to comply with the FDA and prevent off label usage lawsuits that are very common in the pharma industry.